Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
157 | Chinese Journal of Lung Cancer | journal | 0.100 Q4 | 21 | 101 | 101 | 1048 | 0 | 99 | 0.00 | 10.38 | |
156 | Journal of Tumor Marker Oncology | journal | 0.100 Q4 | 9 | 0 | 37 | 0 | 0 | 37 | 0.00 | 0.00 | |
155 | Cancer Molecular Biology | journal | 0.101 Q4 | 4 | 3 | 40 | 87 | 1 | 40 | 0.00 | 29.00 | |
154 | Gann Monographs on Cancer Research | book series | 0.101 Q4 | 10 | 29 | 17 | 1476 | 0 | 16 | 0.00 | 50.90 | |
153 | International Journal of Pediatric Hematology/Oncology | journal | 0.101 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
152 | National Toxicology Program technical report series | journal | 0.101 | 22 | 3 | 13 | 0 | 1 | 13 | 0.00 | 0.00 | |
151 | Leukaemia Risks in Relation to Benzene Exposure | conference and proceedings | 0.102 | 1 | 0 | 9 | 0 | 0 | 9 | 0.00 | 0.00 | |
150 | Oncology Forum | journal | 0.103 Q4 | 1 | 31 | 7 | 219 | 0 | 6 | 0.00 | 7.06 | |
149 | Annals of Cancer Research and Therapy | journal | 0.104 Q4 | 7 | 20 | 23 | 554 | 1 | 22 | 0.11 | 27.70 | |
148 | Biotherapy | journal | 0.107 Q4 | 8 | 75 | 296 | 1595 | 14 | 287 | 0.06 | 21.27 | |
147 | Nowotwory | journal | 0.107 Q4 | 11 | 57 | 63 | 1586 | 5 | 63 | 0.13 | 27.82 | |
146 | Chinese Journal of Cancer Research (discontinued) | journal | 0.108 Q4 | 41 | 66 | 214 | 1077 | 14 | 214 | 0.06 | 16.32 | |
145 | Clinical and Translational Oncology | journal | 0.108 Q4 | 61 | 97 | 218 | 2695 | 21 | 177 | 0.09 | 27.78 | |
144 | Women's Oncology Review | journal | 0.108 | 4 | 12 | 17 | 349 | 1 | 13 | 0.06 | 29.08 | |
143 | Turkish Journal of Cancer | journal | 0.110 Q4 | 10 | 26 | 72 | 524 | 5 | 72 | 0.06 | 20.15 | |
142 | Voprosy Onkologii | journal | 0.110 Q4 | 13 | 118 | 368 | 1897 | 26 | 368 | 0.05 | 16.08 | |
141 | Electronic Journal of Oncology | journal | 0.111 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
140 | Cancer Forum | journal | 0.112 Q4 | 15 | 33 | 94 | 405 | 4 | 92 | 0.05 | 12.27 | |
139 | Journal of B.U.ON. | journal | 0.112 Q4 | 37 | 74 | 238 | 1508 | 15 | 215 | 0.06 | 20.38 | |
138 | Onkologia Polska | journal | 0.117 Q4 | 7 | 30 | 48 | 671 | 4 | 48 | 0.08 | 22.37 | |
137 | UroOncology | journal | 0.118 Q4 | 5 | 25 | 51 | 558 | 3 | 45 | 0.06 | 22.32 | |
136 | Journal of Carcinogenesis | journal | 0.121 Q4 | 43 | 9 | 1 | 372 | 0 | 1 | 0.00 | 41.33 | |
135 | Reports of Practical Oncology and Radiotherapy | journal | 0.121 Q4 | 36 | 15 | 40 | 444 | 8 | 37 | 0.17 | 29.60 | |
134 | Japanese Journal of Cancer and Chemotherapy | journal | 0.128 Q4 | 25 | 415 | 1281 | 1912 | 195 | 1281 | 0.15 | 4.61 | |
133 | Tumor Research | journal | 0.130 Q4 | 3 | 3 | 19 | 51 | 4 | 19 | 0.00 | 17.00 | |
132 | Experimental Oncology | journal | 0.133 Q4 | 48 | 71 | 175 | 1666 | 46 | 173 | 0.26 | 23.46 | |
131 | Cancer Research, Therapy and Control | journal | 0.152 Q4 | 13 | 0 | 47 | 0 | 9 | 47 | 0.25 | 0.00 | |
130 | Breast Disease | journal | 0.165 Q4 | 36 | 19 | 84 | 1702 | 13 | 80 | 0.06 | 89.58 | |
129 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.174 Q4 | 50 | 0 | 70 | 0 | 33 | 70 | 0.62 | 0.00 | |
128 | Asian Pacific Journal of Cancer Prevention | journal | 0.175 Q4 | 91 | 63 | 123 | 1730 | 87 | 97 | 0.88 | 27.46 | |
127 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.181 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
126 | Technology in Cancer Research and Treatment | journal | 0.206 Q4 | 72 | 66 | 62 | 3135 | 62 | 61 | 1.00 | 47.50 | |
125 | Bulletin du Cancer | journal | 0.213 Q4 | 44 | 206 | 547 | 6737 | 364 | 429 | 0.68 | 32.70 | |
124 | Pathogenesis | journal | 0.215 Q4 | 8 | 0 | 7 | 0 | 5 | 7 | 0.00 | 0.00 | |
123 | Clinical Lung Cancer | journal | 0.224 Q4 | 74 | 66 | 161 | 2445 | 51 | 125 | 0.34 | 37.05 | |
122 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.225 Q4 | 35 | 14 | 49 | 525 | 72 | 49 | 1.47 | 37.50 | |
121 | Oncology Research and Treatment | journal | 0.227 Q4 | 55 | 135 | 387 | 2933 | 268 | 334 | 0.95 | 21.73 | |
120 | Tumori | journal | 0.229 Q4 | 59 | 237 | 711 | 3342 | 410 | 684 | 0.52 | 14.10 | |
119 | Breast | journal | 0.239 | 98 | 99 | 331 | 2734 | 131 | 284 | 0.41 | 27.62 | |
118 | Prostate Journal | journal | 0.266 Q4 | 7 | 0 | 48 | 0 | 17 | 43 | 0.35 | 0.00 | |
117 | Prostate Cancer and Prostatic Diseases | journal | 0.283 Q3 | 78 | 61 | 203 | 1282 | 116 | 181 | 0.79 | 21.02 | |
116 | Journal of Brachytherapy International | journal | 0.305 Q3 | 12 | 0 | 62 | 0 | 31 | 61 | 0.52 | 0.00 | |
115 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.314 Q3 | 56 | 54 | 191 | 2211 | 155 | 180 | 0.91 | 40.94 | |
114 | Cancer Treatment and Research | journal | 0.317 Q3 | 65 | 43 | 151 | 4685 | 129 | 151 | 0.90 | 108.95 | |
113 | Cancer Immunity | journal | 0.327 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
112 | Cytotherapy | journal | 0.329 Q3 | 105 | 65 | 184 | 1664 | 138 | 164 | 0.81 | 25.60 | |
111 | Journal of Experimental and Clinical Cancer Research | journal | 0.337 Q3 | 120 | 141 | 291 | 3253 | 276 | 288 | 0.77 | 23.07 | |
110 | Familial Cancer | journal | 0.339 Q3 | 67 | 19 | 32 | 726 | 19 | 29 | 0.59 | 38.21 | |
109 | Neoplasma | journal | 0.339 Q3 | 57 | 78 | 238 | 2299 | 236 | 238 | 0.94 | 29.47 | |
108 | Cancer Cell International | journal | 0.340 Q3 | 80 | 17 | 19 | 689 | 20 | 18 | 1.05 | 40.53 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®